Profit and Loss Results Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
No of Months
12
12
Operating Income
819.00
806.00
Less :Inter divisional transfers
0.00
0.00
Less: Excise
0.00
0.00
Net Sales
819.00
806.00
Expenditure (Ex Depriciation)
Stock Adjustments
-24.00
0.00
Raw Materials Consumed
399.00
389.00
Power & Fuel Cost
18.00
17.00
Employee Cost
127.00
109.00
Operating Expenses
29.00
28.00
General and Administration Expenses
-1.00
-1.00
Selling and Distribution Expenses
47.00
40.00
Cost of Software developments
0.00
0.00
Miscellaneous Expenses
11.00
8.00
Expenses Capitalised
0.00
0.00
Total Expenditure
683.00
659.00
Operating Profit (PBDIT) excl Other Income
136.00
147.00
Other Income
3.00
2.00
Operating Profit (PBDIT)
139.00
149.00
Interest
24.00
16.00
Profit before Depriciation and Tax
115.00
132.00
Depreciation
21.00
17.00
Profit Before Taxation & Exceptional Items
94.00
115.00
Exceptional Income / Expenses
0.00
0.00
Profit Before Tax
94.00
115.00
Provision for Tax
24.00
29.00
Profit After Tax
69.00
86.00
Extraordinary Items
0.00
0.00
Adj to Profit After Tax
0.00
0.00
Profit Balance B/F
352.00
267.00
Profit Available for appropriations
422.00
353.00
Appropriations
422.00
353.00
Equity Dividend (%)
10.00%
10.00%
Earnings Per Share
6.95
8.74
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 1.63% vs NA in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -7.60% vs NA in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 46.04% vs NA in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is -19.14% vs NA in Mar 2024
Compare Profit and Loss Results of Gufic BioScience
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
819.00
398.00
421.00
105.78%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
819.00
398.00
421.00
105.78%
Expenditure (Ex Depriciation)
Stock Adjustments
-24.00
0.00
-24.00
0%
Raw Materials Consumed
399.00
181.00
218.00
120.44%
Power & Fuel Cost
18.00
9.00
9.00
100.00%
Employee Cost
127.00
60.00
67.00
111.67%
Operating Expenses
29.00
24.00
5.00
20.83%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
47.00
3.00
44.00
1,466.67%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
11.00
0.00
11.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
683.00
308.00
375.00
121.75%
Operating Profit (PBDIT) excl Other Income
136.00
89.00
47.00
52.81%
Other Income
3.00
19.00
-16.00
-84.21%
Operating Profit (PBDIT)
139.00
108.00
31.00
28.70%
Interest
24.00
21.00
3.00
14.29%
Profit before Depriciation and Tax
115.00
87.00
28.00
32.18%
Depreciation
21.00
16.00
5.00
31.25%
Profit Before Taxation & Exceptional Items
94.00
70.00
24.00
34.29%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
94.00
70.00
24.00
34.29%
Provision for Tax
24.00
12.00
12.00
100.00%
Profit After Tax
69.00
58.00
11.00
18.97%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
352.00
41.00
311.00
758.54%
Profit Available for appropriations
422.00
100.00
322.00
322.00%
Appropriations
422.00
100.00
322.00
322.00%
Equity Dividend (%)
10%
0%
10.00
Earnings Per Share
6.95
16.12
-9.17
-56.89%
Profit And Loss - Net Sales
Net Sales 819.81 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 1.63% vs NA in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 136.10 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -7.60% vs NA in Mar 2024
Profit And Loss - Interest
Interest 24.52 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 46.04% vs NA in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 69.65 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -19.14% vs NA in Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
